Negev Labs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Venture Capital firm, Negev Capital, holds a portfolio of companies creating neuropsychiatric drugs based on psychedelic molecules.

Rob conleyBeckley psytechKen belotskyLife sciencesCanada filament healthFilament healthNegev capitalUnited kingdom based beckley psytechBio therapeuticsNegev labsMarkets amp regulationsPreclinical researchClinical developmentContract manufacturing amp logisticsMergers and acquisitionsAtient centricity